论文部分内容阅读
目的探讨妈富隆在治疗青春期功血的临床疗效及控制月经周期的临床效果。方法选择青春期功血患者72例,作为研究组,予以妈富隆止血治疗,口服妈富隆1片/d,连续用21d为1周期,3周期为1疗程,控制周期3个月后停药随访半年;同时选择同期病例64例为对照组,予倍美力治疗。结果研究组治疗青春期功血有效率80·56%,对照组79·69%;在控制月经周期上,两组周期相似,周期25～30d,经期4～5d,量少为主。突破性出血,研究组占1·57%,对照组占18·6%两组间有显著意义(P<0·01)。结论妈富隆治疗青春期功血具有很好的临床疗效,方法简便,副作用轻。
Objective To investigate the clinical efficacy of Marvelon in treating adolescent dysfunctional uterine bleeding and the clinical effect of controlling menstrual cycle. Methods 72 cases of adolescent dysfunctional uterine bleeding were selected as the study group. The patients were treated with Marvelon to stop bleeding, oral administration of Marvelon 1 tablet / d, continuous use of 21 days for 1 cycle, 3 cycles for 1 course of treatment, control cycle 3 months after discontinuation of drug for six months At the same time, 64 cases of the same period were selected as the control group and treated with bemeixi. Results The effective rate of adolescent dysfunctional uterine bleeding was 80.56% in the study group and 79.69% in the control group. The control group had similar cycles, 25-30 days and 4-5 days of menstruation. Breakthrough bleeding accounted for 1.57% in the study group and 18.6% in the control group (P <0.01). Conclusion Marvelon treatment of adolescent dysfunctional uterine bleeding has a good clinical efficacy, the method is simple, light side effects.